1Loomba R,Lutrchman G,Kleiner D,et al.Pilot study of metformin in patients with nonalcoholic steatohepatitis.Hepatology,2006,44(1):260A. 被引量：1
2Uygun A,Kadayifci A,Isik AT,et al.Metformin in the treatment of patients with non-alcoholic steatohepatitis.Aliment Pharmacol Ther,2004,19(5):537-544. 被引量：1
3Ratziu V,Giral P,Jacqueminet S,et al.Rosiglitazone for nonalcoholic steatohepatitis:one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.Gastroenterology,2008,135(1):100-110. 被引量：1
4Belfort R,Harrison SA,Brown K,et al.A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.N Engl J Med,2006,355:2297-2307. 被引量：1
5Drucker DJ,Nauck MA.The incretin system:glucagon-like peptide1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2diabetes.Lancet,2006,368 (9548):1696-1705. 被引量：1
6Young AA,Gedulin BR,Bhavsar S,et al.Glucose-lowering and insulin-sensitizing actions of exendin-4.Diabetes,1999,48 (5):1026-1034. 被引量：1
7Hyogo H,Tazuma S,Arihiro K,et al.Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.Metabolism,2008,57(12):1711-1718. 被引量：1
8Gómez-Dominguez E,Gisbert JP,Moreno-Monteagudo JA,et al.A pilot study of atorvastatin treatment in dyslipemid,non-alcoholic fatty liver patient s.Aliment Pharmacol Ther,2006,23 (11):1643-1647. 被引量：1
9Allami Egészségügyi K? zpont,Szakrendelo Intézet,Budapest.Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease.Orv Hetil,2009,24; 150 (21):989-993. 被引量：1
10Nelson A,Torres DM,Morgan AE,et al.A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis:A randomized placebo-controlled trial.J Clin Gastroenterol,2009,43(10):990-994. 被引量：1
